Open AccessPrevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019
Author(s) -
Aikaterini Bilitou,
John Were,
Archie Farrer,
Adrian Rabe,
Simon Wan Yau Ming,
Inaam Haq,
K. Dunton
Publication year - 2022
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s347085
Subject(s) - medicine , dyslipidemia , ezetimibe , population , retrospective cohort study , diabetes mellitus , cohort , incidence (geometry) , primary care , pediatrics , statin , disease , endocrinology , environmental health , physics , family medicine , optics
Guidelines for the management of dyslipidemias recommend intensive low-density lipoprotein (LDL-C) control through lifestyle advice and lipid-lowering drugs to reduce the risk of cardiovascular disease (CVD).